Diagnostic Robotics
Creating a Holistic Patient View

According to reports, 3.8 billion people won’t have access to primary care by 2030. The impact will be most expressed in the ever-growing stress on healthcare systems that are already struggling to keep up with the COVID-19 backlog and the sharper increase of aging populations. This, accompanied by the “great resignation” in the clinical and medical space, implies a loss of clinical and operational knowledge.

This is where Diagnostic Robotics can help.

Operating as a Mayo Clinic Platform portfolio company, Diagnostic Robotics assists healthcare plans, and risk-taking, or value-based care providers with the implementation of proactive patient treatment plans leveraging patient historical medical information along with clinical triage. The company developed artificial intelligence (AI) solutions to refine patient risk prediction in a significant and more accurate manner to improve patient outcomes and existing treatment paths as well as reduce cost of care.

The Diagnostic Robotics platform identifies cost savings opportunities by providing care managers and clinicians with robust and actionable insights in real-time to identify future high-risk/high-cost patients for whom interventions would be most helpful along with treatment pathways that are most likely to improve outcomes.

“We have developed a risk stratification solution, which is coupled with historical AI-driven mining of claims and medical records to accurately predict a patient’s treatment needs, clinical journey, and likely outcomes, while optimizing for clinical ROI,” says Dr. Kira Radinsky, Founder and CEO of Diagnostic Robotics.
By leveraging over 60B claims data points and 100m+ medical records with clinically validated real-time prioritization of patients, Diagnostic Robotics has helped clients proactively reach around 28 million patients monthly and has reached a $17k per member per year savings among its customer successes. The company has shown a 2X inpatient care reduction when compared to a control group across multiple clinical programs in its platform, such as avoidable emergency room visits and CHF.

For instance, Diagnostic Robotics carried out a multi-year program for a top five national health plan. The aim was to prevent avoidable emergency department visits by reaching out to members before they deteriorated and offering a variety of interventions, such as different forms of education and optimized care navigation. The results, compared to a control group, netted to a four times reduction in ER visits and associated costs.

In another instance, Diagnostic Robotics worked with a regional health plan to boost their CHF management program’s ROI by shifting the focus to members who are more likely to engage with and clinically succeed in the program. The company’s solution empowered care management teams with prioritized reports, a data visualization dashboard, and clinical async digital outreach, which enabled them to easily access members’ real-time medical history, key risk drivers, critical health issues, and diagnoses.

Diagnostic Robotics’ team has more than 100 years of combined healthcare experience and a mission to improve healthcare worldwide.